Havas enters the creator-led, serialized content space with Shape Shifting, a new platform to help brands lead cultural and health conversations.
, /PRNewswire/ – Havas launched Shape Shifting — its first-ever creator-led, serialized content platform focused on the unfolding GLP-1 revolution — at the 2025 Consumer Electronics Show (CES). By combining medical and cultural expertise with episodic content targeted to GLP-1-curious and current users, this platform marks Havas’ bold step into building an editorially driven media property.
In partnership with Made In Network, one of the world’s leading producers and publishers of creator-led programming, Shape Shifting explores the cultural and scientific transformation sparked by GLP-1 medications like Ozempic, Wegovy, and Mounjaro.
Amidst the crowded social conversation on the topic, Shape Shiftingprovides an objective and trusted, science-led alternative to separate fact from fiction. Created in partnership with medical professionals and creative leaders, the series educates audiences on the profound micro and macro shifts in culture associated with GLP-1 …